TrialSpark

The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.

This new round of funding brings the company's total raise to $250 million. 

The partners announced that they are putting out a request for clinical trial proposals in the areas of dermatology, gastroenterology, pulmonology, endocrinology, ophthalmology, inflammatory diseases, neurology, women’s health and rare diseases.